Wyzgal J - Search Results

1

The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial.

Durlik M, Paczek L, Rutkowski B, Lewandowska D, Debska-Slizien A, Chamienia A, Wyzgal J, Ognista-Gajda A, Niemczyk M. Durlik M, et al. Among authors: wyzgal j. Ann Transplant. 2010 Jul-Sep;15(3):51-9. Ann Transplant. 2010. PMID: 20877267 Clinical Trial.

2

Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients--long term results.

Samsel R, Pliszczyński J, Chmura A, Korczak G, Włodarczyk Z, Cieciura T, Lagiewska B, Glyda M, Wyzgal J, Paczek L, Durlik M, Rowiński W. Samsel R, et al. Among authors: wyzgal j. Ann Transplant. 2008;13(1):32-9. Ann Transplant. 2008. PMID: 18344941 Free article. Clinical Trial.

3

Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients.

Żochowska D, Wyzgał J, Pączek L. Żochowska D, et al. Among authors: wyzgal j. Ann Transplant. 2012 Jul-Sep;17(3):36-44. doi: 10.12659/aot.883456. Ann Transplant. 2012. PMID: 23018254

4

Sirolimus-associated hepatotoxicity in the kidney graft recipient.

Niemczyk M, Wyzgał J, Perkowska A, Porowski D, Paczek L. Niemczyk M, et al. Among authors: wyzgal j. Transpl Int. 2005 Nov;18(11):1302-3. doi: 10.1111/j.1432-2277.2005.00210.x. Transpl Int. 2005. PMID: 16221163 Free article.

5

Economic evaluation of sirolimus-based immunosuppressive regimens in kidney graft recipients.

Niemczyk M, Nowak M, Pilecki T, Wyzgał J, Ziółkowski J, Zygier D, Paczek L. Niemczyk M, et al. Among authors: wyzgal j. Transplant Proc. 2006 Jan-Feb;38(1):74-7. doi: 10.1016/j.transproceed.2005.11.092. Transplant Proc. 2006. PMID: 16504668

6

Early hyperglycemia after allogenic kidney transplantation.

Wyzgal J, Paczek L, Ziolkowski J, Pawlowska M, Rowiński W, Durlik M. Wyzgal J, et al. Ann Transplant. 2007;12(1):40-5. Ann Transplant. 2007. PMID: 17953142 Free article.

7

The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.

Korczak-Kowalska G, Wierzbicki P, Bocian K, Klosowska D, Niemczyk M, Wyzgal J, Korecka A, Durlik M, Chmura A, Paczek L, Górski A. Korczak-Kowalska G, et al. Among authors: wyzgal j. Transplant Proc. 2007 Nov;39(9):2721-3. doi: 10.1016/j.transproceed.2007.09.015. Transplant Proc. 2007. PMID: 18021968

8

Results of a 6-month, multicenter, open-label, prospective study concerning efficacy and safety of mycophenolate sodium in de novo kidney transplant recipients.

Wyzgał J, Niemczyk M, Ziółkowski J, Durlik M, Wiecek A. Wyzgał J, et al. Transplant Proc. 2007 Nov;39(9):2730-2. doi: 10.1016/j.transproceed.2007.08.071. Transplant Proc. 2007. PMID: 18021971 Clinical Trial.

9

Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors.

Wyzgał J, Paczek L, Sańko-Resmer J, Ciszek M, Nowak M, Rowiński W, Szmidt J, Durlik M. Wyzgał J, et al. Ann Transplant. 2007;12(2):26-9. Ann Transplant. 2007. PMID: 18173063

10

Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.

Niemczyk M, Zegarska J, Pawłowska M, Wyzgał J, Ciszek M, Paczek L. Niemczyk M, et al. Among authors: wyzgal j. Transpl Immunol. 2009 Jan;20(3):139-42. doi: 10.1016/j.trim.2008.09.005. Epub 2008 Oct 1. Transpl Immunol. 2009. PMID: 18834941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters